Alpha fetoprotein antagonises benzyl isothiocyanate inhibition of the malignant behaviors of hepatocellular carcinoma cells
Open Access
- 3 October 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (46) , 75749-75762
Abstract
Alpha fetoprotein antagonises benzyl isothiocyanate inhibition of the malignant behaviors of hepatocellular carcinoma cellsKeywords
This publication has 50 references indexed in Scilit:
- In-vitro growth inhibition of chemotherapy and molecular targeted agents in hepatocellular carcinomaAnti-Cancer Drugs, 2013
- Alpha‐fetoprotein: A new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell linesInternational Journal of Cancer, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survivalBMC Cancer, 2009
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- Benzyl isothiocyanate inhibits metalloproteinase-2/-9 expression by suppressing the mitogen-activated protein kinase in SK-Hep1 human hepatoma cellsFood and Chemical Toxicology, 2008
- Glucoraphanin, the bioprecursor of the widely extolled chemopreventive agent sulforaphane found in broccoli, induces Phase-I xenobiotic metabolizing enzymes and increases free radical generation in rat liverMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2006
- Diagnosis of Small Hepatocellular Carcinoma * #Hepatology, 2005
- Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1 ribozymesHepatology, 2002
- Inhibitory Effects of Benzyl Isothiocyanate and Benzyl Thiocyanate on Diethylnitrosamine‐induced Hepatocarcinogenesis in RatsJapanese Journal of Cancer Research, 1993